Polaris AI Pharma Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
162
- Stock Symbol
-
041910
- Investments
-
9
- Share Price
-
$4.08
- (As of Thursday Closing)
Polaris AI Pharma General Information
Description
Polaris AI Pharma Corp is engaged in the production of raw pharmaceutical ingredients. It focuses on generic drugs and produces about 40 types of raw medicines, including asthma treatments, gastric ulcer treatments, and alcohol dependence treatments, and supplies them domestically and internationally.
Contact Information
Website
www.polarisaipharma.comCorporate Office
- 25 Barangongdan-ro
- Hyangnam-eup
- Hwaseong, Gyeonggi
- South Korea
Corporate Office
- 25 Barangongdan-ro
- Hyangnam-eup
- Hwaseong, Gyeonggi
- South Korea
Polaris AI Pharma Timeline
Polaris AI Pharma Stock Performance
As of 12-Nov-2026, Polaris AI Pharma’s stock price is $4.08. Its current market cap is $54.3M with 13.3M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.08 | $4.07 | $2.66 - $6.78 | $54.3M | 13.3M | 62.7K | $0.74 |
Polaris AI Pharma Financials Summary
As of 30-Jun-2026, Polaris AI Pharma has a trailing 12-month revenue of $39.5M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 38,801 | 67,343 | 20,869 | 41,876 |
| Revenue | 39,534 | 39,029 | 43,683 | 49,115 |
| EBITDA | 13,772 | 6,264 | 3,962 | 4,659 |
| Net Income | 9,843 | 4,329 | 2,893 | 2,925 |
| Total Assets | 127,470 | 136,061 | 91,279 | 94,592 |
| Total Debt | 24,152 | 35,267 | 518 | 954 |
Polaris AI Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Polaris AI Pharma Patents
Polaris AI Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018079984-A1 | Fast-acting complex tablet containing dutasteride and tadalafil | Inactive | 25-Oct-2016 | ||
| WO-2016144023-A1 | Tablet containing tenofovir disoproxil free base and preparation method therefor | Inactive | 12-Mar-2015 | ||
| WO-2014035107-A1 | Method for purifying fluvoxamine free base and method for preparing highly pure fluvoxamine maleate using same | Inactive | 29-Aug-2012 | ||
| JP-2014031360-A | Anhydrous aripiprazole crystal and method for producing the same | Pending | 02-Aug-2012 | ||
| WO-2014021652-A1 | Anhydrous aripiprazole crystals and production method for same | Inactive | 02-Aug-2012 | C07D311/20 |
Polaris AI Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Polaris AI Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Polaris AI Pharma Investments (9)
Polaris AI Pharma’s most recent deal was a Later Stage VC with The.Wave.Talk for . The deal was made on 01-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| The.Wave.Talk | 01-Jan-2022 | Later Stage VC | Electronic Equipment and Instruments | ||
| Bilix | 01-Oct-2021 | Seed Round | Drug Discovery | ||
| Curogen Technology | 26-Apr-2021 | Early Stage VC | Drug Discovery | ||
| NeogenTC | 21-Dec-2020 | Seed Round | Drug Discovery | ||
| iNtRON Biotechnology | 21-Dec-2020 | PIPE | Drug Discovery |
Polaris AI Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Polaris AI Pharma FAQs
-
When was Polaris AI Pharma founded?
Polaris AI Pharma was founded in 1996.
-
Where is Polaris AI Pharma headquartered?
Polaris AI Pharma is headquartered in Hwaseong, South Korea.
-
What is the size of Polaris AI Pharma?
Polaris AI Pharma has 162 total employees.
-
What industry is Polaris AI Pharma in?
Polaris AI Pharma’s primary industry is Pharmaceuticals.
-
Is Polaris AI Pharma a private or public company?
Polaris AI Pharma is a Public company.
-
What is Polaris AI Pharma’s stock symbol?
The ticker symbol for Polaris AI Pharma is 041910.
-
What is the current stock price of Polaris AI Pharma?
As of 12-Nov-2026 the stock price of Polaris AI Pharma is $4.08.
-
What is the current market cap of Polaris AI Pharma?
The current market capitalization of Polaris AI Pharma is $54.3M.
-
What is Polaris AI Pharma’s current revenue?
The trailing twelve month revenue for Polaris AI Pharma is $39.5M.
-
What is Polaris AI Pharma’s annual earnings per share (EPS)?
Polaris AI Pharma’s EPS for 12 months was $0.74.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
